Sehgal A, Galbraith A, Chesney M, Schoenfeld P, Charles G, Lo B
Department of Veterans Affairs, Robert Wood Johnson Clinical Scholars Program, University of California, San Francisco 94143.
JAMA. 1992 Jan 1;267(1):59-63.
The Cruzan case and the Patient Self-Determination Act will encourage patients to specify in advance which life-sustaining treatments they would want if they become mentally incompetent. However, strictly following such advance directives may not always be in a patient's best interests. We sought to determine whether patients differ in how strictly they want advance directives followed.
Interview study.
Seven outpatient chronic dialysis centers.
One hundred fifty mentally competent dialysis patients.
Using a structured questionnaire, we asked the subjects whether they would want dialysis continued or stopped if they developed advanced Alzheimer's disease. We then asked how much leeway their physician and surrogate should have to override that advance directive if overriding were in their best interests. Subjects granting leeway were also asked what factors should be considered in making decisions for them.
Subjects varied greatly in how much leeway they would give surrogates to override their advance directives: "no leeway" (39%), "a little leeway" (19%), "a lot of leeway" (11%), and "complete leeway" (31%). Subjects also varied in how much they wanted various factors considered in making decisions, such as pain or suffering, quality of life, possibility of a new treatment, indignity caused by continued treatment, financial impact of treatment on family members, and religious beliefs.
Strictly following all advance directives may not truly reflect patients' preferences. To improve advance directives, we recommend that physicians explicitly ask patients how strictly they want their advance directives followed and what factors they want considered in making decisions.
克鲁赞案及《患者自主决定法》将鼓励患者提前明确如果他们丧失心智能力,希望接受哪些维持生命的治疗。然而,严格遵循此类预先指示未必总是符合患者的最佳利益。我们试图确定患者在希望预先指示被遵循的严格程度上是否存在差异。
访谈研究。
7个门诊慢性透析中心。
150名心智健全的透析患者。
我们使用一份结构化问卷,询问受试者如果他们患上晚期阿尔茨海默病,是希望继续还是停止透析。然后我们询问如果违背预先指示符合他们的最佳利益,他们的医生和代理人应有多大的变通余地。给予变通余地的受试者还被问及在为他们做决定时应考虑哪些因素。
受试者在给予代理人违背其预先指示的变通程度上差异很大:“没有变通余地”(39%)、“有一点变通余地”(19%)、“有很大变通余地”(11%)和“完全变通余地”(31%)。受试者在希望决策时考虑各种因素的程度上也存在差异,如疼痛或痛苦、生活质量、新治疗方法的可能性、继续治疗造成的尊严丧失、治疗对家庭成员的经济影响以及宗教信仰。
严格遵循所有预先指示可能无法真正反映患者的偏好。为改进预先指示,我们建议医生明确询问患者希望其预先指示被遵循的严格程度以及他们希望在决策时考虑哪些因素。